Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-01-02 Sale |
2024-01-04 9:47 pm |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan Chief Business Officer |
31,900 | $16.59 | $529,194 | 242,683 (Direct) |
View |
| 2024-01-03 Sale |
2024-01-04 9:46 pm |
Dyne Therapeutics Inc. | DYN | Scalzo Richard William SVP, Head of Finance & Admin. |
13,000 | $18.81 | $244,530 | 149,968 (Direct) |
View |
| 2023-12-14 Sale |
2023-12-14 4:59 pm |
Dyne Therapeutics Inc. | DYN | Scalzo Richard William See Remarks |
2,376 | $12.02 | $28,560 | 124,228 (Direct) |
View |
| 2023-12-11 Sale |
2023-12-12 5:35 pm |
Dyne Therapeutics Inc. | DYN | Scalzo Richard William See Remarks |
1,380 | $10.72 | $14,794 | 126,604 (Direct) |
View |
| 2023-12-11 Sale |
2023-12-12 5:34 pm |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan Chief Business Officer |
1,245 | $10.72 | $13,346 | 155,518 (Direct) |
View |
| 2023-12-11 Sale |
2023-12-12 5:34 pm |
Dyne Therapeutics Inc. | DYN | HIGH SUSANNA GATTI Chief Operating Officer |
1,616 | $10.72 | $17,324 | 187,882 (Direct) |
View |
| 2023-12-11 Sale |
2023-12-12 5:33 pm |
Dyne Therapeutics Inc. | DYN | Farwell Wildon Chief Medical Officer |
2,666 | $10.66 | $28,413 | 169,096 (Direct) |
View |
| 2023-12-11 Sale |
2023-12-12 5:33 pm |
Dyne Therapeutics Inc. | DYN | Brumm Joshua T See Remarks |
7,585 | $10.72 | $81,311 | 584,971 (Direct) |
View |
| 2023-12-11 Sale |
2023-12-12 5:32 pm |
Dyne Therapeutics Inc. | DYN | Beskrovnaya Oxana Chief Scientific Officer |
1,467 | $10.72 | $15,726 | 176,585 (Direct) |
View |
| 2023-12-04 Sale |
2023-12-06 6:13 pm |
Dyne Therapeutics Inc. | DYN | Scalzo Richard William See Remarks |
2,553 | $12.01 | $30,662 | 127,984 (Direct) |
View |
| 2023-11-02 Sale |
2023-11-02 5:16 pm |
Dyne Therapeutics Inc. | DYN | HIGH SUSANNA GATTI Chief Operating Officer |
9,939 | $7.4 | $73,549 | 94,605 (Direct) |
View |
| 2023-09-18 Sale |
2023-09-20 4:49 pm |
Dyne Therapeutics Inc. | DYN | Scalzo Richard William See Remarks |
1,290 | $9.41 | $12,139 | 40,795 (Direct) |
View |
| 2023-09-18 Sale |
2023-09-20 4:49 pm |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan Chief Business Officer |
1,261 | $9.41 | $11,866 | 60,605 (Direct) |
View |
| 2023-09-18 Sale |
2023-09-20 4:48 pm |
Dyne Therapeutics Inc. | DYN | HIGH SUSANNA GATTI Chief Operating Officer |
2,672 | $9.41 | $25,144 | 104,544 (Direct) |
View |
| 2023-09-18 Sale |
2023-09-20 4:47 pm |
Dyne Therapeutics Inc. | DYN | Brumm Joshua T See Remarks |
12,032 | $9.41 | $113,221 | 233,679 (Direct) |
View |
| 2023-09-18 Sale |
2023-09-20 4:47 pm |
Dyne Therapeutics Inc. | DYN | Beskrovnaya Oxana Chief Scientific Officer |
1,436 | $9.41 | $13,513 | 84,334 (Direct) |
View |
| 2023-09-12 Sale |
2023-09-13 7:56 pm |
Dyne Therapeutics Inc. | DYN | Farwell Wildon Chief Medical Officer |
1,707 | $10.41 | $17,770 | 89,250 (Direct) |
View |
| 2023-09-12 Sale |
2023-09-13 7:53 pm |
Dyne Therapeutics Inc. | DYN | Scalzo Richard William See Remarks |
1,397 | $10.41 | $14,543 | 42,085 (Direct) |
View |
| 2023-09-12 Sale |
2023-09-13 7:53 pm |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan Chief Business Officer |
1,266 | $10.41 | $13,179 | 61,866 (Direct) |
View |
| 2023-09-12 Sale |
2023-09-13 7:51 pm |
Dyne Therapeutics Inc. | DYN | HIGH SUSANNA GATTI Chief Operating Officer |
1,635 | $10.41 | $17,020 | 107,216 (Direct) |
View |
| 2023-09-12 Sale |
2023-09-13 7:50 pm |
Dyne Therapeutics Inc. | DYN | Brumm Joshua T See Remarks |
7,672 | $10.41 | $79,866 | 245,711 (Direct) |
View |
| 2023-09-12 Sale |
2023-09-13 7:50 pm |
Dyne Therapeutics Inc. | DYN | Beskrovnaya Oxana Chief Scientific Officer |
1,484 | $10.41 | $15,448 | 85,770 (Direct) |
View |
| 2023-06-13 Sale |
2023-06-15 5:46 pm |
Dyne Therapeutics Inc. | DYN | Scalzo Richard William See Remarks |
51,390 | $12.71 | $653,178 | 82,222 (Direct) |
View |
| 2023-06-12 Sale |
2023-06-14 6:40 pm |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan See Remarks |
2,259 | $12.68 | $28,649 | 63,132 (Direct) |
View |
| 2023-06-13 Sale |
2023-06-14 6:40 pm |
Dyne Therapeutics Inc. | DYN | HIGH SUSANNA GATTI Chief Operating Officer |
1,625 | $12.43 | $20,199 | 108,851 (Direct) |
View |
| 2023-06-13 Sale |
2023-06-14 6:40 pm |
Dyne Therapeutics Inc. | DYN | Farwell Wildon Chief Medical Officer |
1,698 | $12.43 | $21,106 | 90,957 (Direct) |
View |
| 2023-06-13 Sale |
2023-06-14 6:39 pm |
Dyne Therapeutics Inc. | DYN | Beskrovnaya Oxana Chief Scientific Officer |
1,475 | $12.43 | $18,334 | 87,254 (Direct) |
View |
| 2023-06-08 Sale |
2023-06-12 9:22 pm |
Dyne Therapeutics Inc. | DYN | Brumm Joshua T See Remarks |
325,330 | $12.9 | $4,195,797 | 881,842 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-01-03 Exercise |
2024-01-04 9:47 pm |
N/A N/A |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan Chief Business Officer |
20,000 | $0.73 | 242,683 (Direct) |
View |
| 2024-01-03 Exercise |
2024-01-04 9:47 pm |
N/A 2029-02-25 |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan Chief Business Officer |
20,000 | $0 | 242,683 (Direct) |
View |
| 2024-01-03 Exercise |
2024-01-04 9:46 pm |
N/A 2030-01-05 |
Dyne Therapeutics Inc. | DYN | Scalzo Richard William SVP, Head of Finance & Admin. |
13,000 | $0 | 149,968 (Direct) |
View |
| 2024-01-03 Exercise |
2024-01-04 9:46 pm |
N/A N/A |
Dyne Therapeutics Inc. | DYN | Scalzo Richard William SVP, Head of Finance & Admin. |
13,000 | $1.03 | 149,968 (Direct) |
View |
| 2023-11-15 Option Award |
2023-11-16 4:35 pm |
N/A 2033-11-14 |
Dyne Therapeutics Inc. | DYN | Scalzo Richard William See Remarks |
124,688 | $0 | 165,483 (Direct) |
View |
| 2023-11-15 Option Award |
2023-11-16 4:34 pm |
N/A 2033-11-14 |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan Chief Business Officer |
133,603 | $0 | 194,208 (Direct) |
View |
| 2023-11-15 Option Award |
2023-11-16 4:30 pm |
N/A 2033-11-14 |
Dyne Therapeutics Inc. | DYN | HIGH SUSANNA GATTI Chief Operating Officer |
131,845 | $0 | 226,450 (Direct) |
View |
| 2023-11-15 Option Award |
2023-11-16 4:29 pm |
N/A 2033-11-14 |
Dyne Therapeutics Inc. | DYN | Farwell Wildon Chief Medical Officer |
114,643 | $0 | 203,893 (Direct) |
View |
| 2023-11-15 Option Award |
2023-11-16 4:29 pm |
N/A 2033-11-14 |
Dyne Therapeutics Inc. | DYN | Brumm Joshua T See Remarks |
498,627 | $0 | 732,306 (Direct) |
View |
| 2023-11-15 Option Award |
2023-11-16 4:23 pm |
N/A 2033-11-14 |
Dyne Therapeutics Inc. | DYN | Beskrovnaya Oxana Chief Scientific Officer |
130,213 | $0 | 214,547 (Direct) |
View |
| 2023-06-13 Exercise |
2023-06-15 5:46 pm |
N/A 2030-01-05 |
Dyne Therapeutics Inc. | DYN | Scalzo Richard William See Remarks |
40,000 | $0 | 82,222 (Direct) |
View |
| 2023-06-13 Exercise |
2023-06-15 5:46 pm |
N/A N/A |
Dyne Therapeutics Inc. | DYN | Scalzo Richard William See Remarks |
40,000 | $1.03 | 82,222 (Direct) |
View |
| 2023-06-08 Exercise |
2023-06-12 9:22 pm |
N/A 2030-01-05 |
Dyne Therapeutics Inc. | DYN | Brumm Joshua T See Remarks |
278,030 | $0 | 881,842 (Direct) |
View |
| 2023-06-08 Gift |
2023-06-12 9:22 pm |
N/A N/A |
Dyne Therapeutics Inc. | DYN | Brumm Joshua T See Remarks |
21,800 | $0 | 881,842 (Direct) |
View |
| 2023-06-08 Exercise |
2023-06-12 9:22 pm |
N/A N/A |
Dyne Therapeutics Inc. | DYN | Brumm Joshua T See Remarks |
278,030 | $1.03 | 881,842 (Direct) |
View |
| 2023-05-24 Option Award |
2023-05-25 6:38 pm |
N/A 2033-05-23 |
Dyne Therapeutics Inc. | DYN | Stehman-Breen Catherine Director |
24,900 | $0 | 24,900 (Direct) |
View |
| 2023-05-24 Option Award |
2023-05-25 6:38 pm |
N/A 2033-05-23 |
Dyne Therapeutics Inc. | DYN | Rhodes Jason P Director |
24,900 | $0 | 24,900 (Direct) |
View |
| 2023-05-24 Option Award |
2023-05-25 6:37 pm |
N/A 2033-05-23 |
Dyne Therapeutics Inc. | DYN | Lubner David Charles Director |
24,900 | $0 | 24,900 (Direct) |
View |
| 2023-05-24 Option Award |
2023-05-25 6:37 pm |
N/A 2033-05-23 |
Dyne Therapeutics Inc. | DYN | Kersten Dirk Director 10% Owner |
24,900 | $0 | 24,900 (Direct) |
View |
| 2023-05-24 Option Award |
2023-05-25 6:37 pm |
N/A 2033-05-23 |
Dyne Therapeutics Inc. | DYN | Incerti Carlo Director |
24,900 | $0 | 24,900 (Direct) |
View |
| 2023-05-24 Option Award |
2023-05-25 6:36 pm |
N/A 2033-05-23 |
Dyne Therapeutics Inc. | DYN | HURWITZ EDWARD Director |
24,900 | $0 | 24,900 (Direct) |
View |